Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-27T23:23:06.643Z Has data issue: false hasContentIssue false

19 - Intra-cellular tyrosine kinase

from Part 2.1 - Molecular pathways underlying carcinogenesis: signal transduction

Published online by Cambridge University Press:  05 February 2015

Rosalyn B. Irby
Affiliation:
Penn State Hershey Cancer Institute H046, Penn State University College of Medicine, Hershey, PA, USA
Timothy J. Yeatman
Affiliation:
Gibbs Cancer Center and Research Institute, Spartanburg, SC, USA
Edward P. Gelmann
Affiliation:
Columbia University, New York
Charles L. Sawyers
Affiliation:
Memorial Sloan-Kettering Cancer Center, New York
Frank J. Rauscher, III
Affiliation:
The Wistar Institute Cancer Centre, Philadelphia
Get access

Summary

Introduction

Protein kinases are proteins that enzymatically add a phosphate, obtained from ATP, to an OH group on certain amino acids in a protein. They are divided into two major groups: serine/threonine kinases phosphorylate serine or threonine residues; tyrosine kinases phosphorylate tyrosine residues (1). Dual-specificity kinases, such as Mek, phosphorylate all three amino acid residues. Phosphorylation causes a conformational change in the target protein by the addition of a bulky, charged group (Figure 19.1) to the protein. This causes alteration of the activity, subcellular location, or protein–protein interactions of phosphorylated proteins.

Phosphorylation is a rapid method of activating and inactivating proteins and significantly altering pathway activities. Phosphorylation regulates cell adhesion, cell-cycle progression, transcription-factor activity, and general metabolism in the cell. As a result, phosphorylation events must be tightly regulated. Most tyrosine kinase targets have an associated protein phosphatase, designed to reverse the effects of phosphorylation rapidly. Often phosphorylation results in the addition or removal of a regulatory protein that either interferes with binding of the target protein to a substrate or maintains it in a separate subcellular compartment away from the substrate. Perturbation of the pathways can cause dysregulation of cellular activities and lead to a number of disorders, including malignancy. It has been stated that cancer is fundamentally a disease of aberrant kinase activity and signal transduction (2).

Type
Chapter
Information
Molecular Oncology
Causes of Cancer and Targets for Treatment
, pp. 231 - 242
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hubbard, SR, Till, JH. Protein tyrosine kinase structure and function. Annual Review of Biochemistry 2000;69:373–98.CrossRef
Mikalsen, T, Gerits, N, Moens, U. Inhibitors of signal transduction protein kinases as targets for cancer therapy. Biotechnology Annual Review, 2006;12:153–223.CrossRef
Manning, G, Whyte, DB, Martinez, R, Hunter, T, Sudarsanam, S. The protein kinase complement of the human genome. Science 2002;298:1912–34.CrossRef
Hubbard, SR, Mohammadi, M, Schlessinger, J.Autoregulatory mechanisms in protein-tyrosine kinases. Journal of Biological Chemistry, 1998;273:11 987–90.CrossRefGoogle ScholarPubMed
Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 2000;103:211–25.CrossRef
Venter, JC, Adams, MD, Myers, EW, et al. The sequence of the human genome. Science 2001;291:1304–51.CrossRef
Gu, J, Gu, X. Natural history and functional divergence of protein tyrosine kinases. Gene 2003;317:49–57.CrossRef
Chang, YM, Kung, HJ, Evans, CP. Nonreceptor tyrosine kinases in prostate cancer. Neoplasia 2007;9:90–100.CrossRef
Cho, NL, Lin, C-I, Du, J, et al. Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers. Biochemical and Biophysical Research Communications 2012;421:508–13.CrossRef
Azoitei, N, Brey, A, Buoch, T, et al. Thirty-eight negative kinase 1 (TNK1) facilitates TNF α-induced apoptosis by blocking NF-kappaB activation. Oncogene 2007;26(45):6536–45.CrossRef
Blume-Jensen, P, Hunter, T. Oncogenic kinase signalling. Nature 2001;411:355–65.CrossRef
Rous, P.A sarcoma of the fowl transmissible by an agent separable from the tumor cells. Journal of Experimental Medicine 1911;13:397–411.CrossRefGoogle ScholarPubMed
Thomas, SM, Brugge, JS. Cellular functions regulated by Src family kinases. Annual Review of Cell and Developmental Biology 1997;13:513–609.CrossRef
Martin, GS. The hunting of the Src. Nature Reviews Molecular and Cell Biology 2001;2:467–75.CrossRef
Nam, S, Kim, D, Cheng, JQ, et al. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Cancer Research 2005;65:9185–9.CrossRef
Goff, SP, Gilboa, E, Witte, ON, Baltimore, D. Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell 1980;22:777–85.CrossRef
Kruh, GD, Perego, R, Miki, T, Aaronson, SA. The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proceedings of the National Academy of Sciences USA 1990;87:5802–6.CrossRef
Pendergast, AM. The Abl family kinases: mechanisms of regulation and signaling. Advances in Cancer Research 2002;85:51–100.CrossRef
Bene, MC. What is ZAP-70? Cytometry B, Clinical Cytometry 2006;70:204–8.
Kipps, TJ. The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia. Best Practice and Research: Clinical Haematology 2007;20:415–24.
Gu, JJ, Ryu, JR, Pendergast, AM. Abl tyrosine kinases in T-cell signaling. Immunology Review 2009;228:170–83.CrossRef
Haan, C, Kreis, S, Margue, C, Behrmann, I. Jaks and cytokine receptors – an intimate relationship. Biochemical Pharmacology 2006;72:1538–46.CrossRef
Saharinen, P, Silvennoinen, O.The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction. Journal of Biological Chemistry, 2002;277:47 954–63.CrossRefGoogle ScholarPubMed
Frank, SJ, Yi, W, Zhao, Y, et al. Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. Journal of Biological Chemistry, 1995;270:14 776–85.CrossRefGoogle ScholarPubMed
Bromberg, JF, Horvath, CM, Besser, D, Lathem, WW, Darnell, JE Stat3 activation is required for cellular transformation by v-src. Molecular and Cellular Biology 1998;18:2553–8.CrossRef
Bromberg, JF, Wrzeszczynska, MH, Devgan, G, et al. Stat3 as an oncogene [erratum in Cell 1999;99:239]. Cell 1999;98:295–303.
Feller, SM, Ren, R, Hanafusa, H, Baltimore, D. SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. Trends in Biochemical Science, 1994;19:453–8.CrossRef
Gonfloni, S, Williams, JC, Hattula, K, et al. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src. EMBO Journal, 1997;16:7261–71.CrossRef
Schlessinger, J, Lemmon, MA. SH2 and PTB domains in tyrosine kinase signaling. Science STKE 2003:RE12.
Radtke, S, Hermanns, HM, Haan, C, et al. Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression. Journal of Biological Chemistry, 2002;277:11 297–305.CrossRefGoogle ScholarPubMed
Posern, G, Zheng, J, Knudsen, BS, et al. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G. Oncogene 1998;16:1903–12.CrossRef
Shishido, T, Akagi, T, Chalmers, A, et al. Crk family adaptor proteins trans-activate c-Abl kinase. Genes and Cells 2001;6:431–40.CrossRef
Yoshida, K. Regulation for nuclear targeting of the Abl tyrosine kinase in response to DNA damage. Advances in Experimental Medicine and Biology, 2007;604:155–65.CrossRef
Chong, ZZ, Maiese, K. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histology and Histopathology 2007;22:1251–67.
McKay, MM, Morrison, DK. Integrating signals from RTKs to ERK/MAPK. Oncogene 2007;26:3113–21.CrossRef
Mustelin, T, Hunter, T. Meeting at mitosis: cell cycle-specific regulation of c-Src by RPTP alpha. Science STKE, 2002:PE3.
Shenoy, S, Chackalaparampil, I, Bagrodia S, Lin PH, Shalloway D. Role of p34cdc2-mediated phosphorylations in two-step activation of pp60c-src during mitosis. Proceedings of the National Academy of Sciences USA 1992;89:7237–41.CrossRef
Tracy, S, van der Geer, P, Hunter, T.The receptor-like protein-tyrosine phosphatase, RPTP alpha, is phosphorylated by protein kinase C on two serines close to the inner face of the plasma membrane. Journal of Biological Chemistry, 1995;270:10 587–94.CrossRefGoogle ScholarPubMed
Zheng, XM, Resnick, RJ, Shalloway, D.Mitotic activation of protein-tyrosine phosphatase alpha and regulation of its Src-mediated transforming activity by its sites of protein kinase C phosphorylation. Journal of Biological Chemistry, 2002;277:21 922–9.CrossRefGoogle ScholarPubMed
Zheng, XM, Shalloway, D. Two mechanisms activate PTPalpha during mitosis. EMBO Journal, 2001;20:6037–49.CrossRef
Fleming, RY, Ellis, LM, Parikh, NU, et al. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by activity of src kinase. Surgery 1997;122:501–7.CrossRef
Munshi, N, Groopman, JE, Gill, PS, Ganju, RK.c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells. Journal of Immunology 2000;164:1169–74.CrossRefGoogle ScholarPubMed
Biscardi, JS, Maa, MC, Tice, DA, et al. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. Journal of Biological Chemistry, 1999;274:8335–43.CrossRefGoogle ScholarPubMed
Tice, DA, Biscardi, JS, Nickles, AL, Parsons, SJ. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proceedings of the National Academy of Sciences USA 1999;96:1415–20.CrossRef
Maa, M, Leu, T, McCarley, D, Schatzman, R, Parsons, S. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proceedings of the National Academy of Sciences USA 1995;92:6981–5.CrossRef
Mao, W, Irby, R, Coppola, D, et al. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene 1997;15:3083–90.CrossRef
Schaller, MD, Hildebrand, JD, Shannon, JD, et al. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Molecular and Cell Biology, 1994;14:1680–8.CrossRef
Parsons, JT.Focal adhesion kinase: the first ten years. Journal of Cell Science 2003;116:1409–16.CrossRefGoogle ScholarPubMed
Grant, SG, O’Dell, TJ, Karl, KA, et al. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 1992;258:1903–10.CrossRef
Karaghiosoff, M, Neubauer, H, Lassnig, C, et al. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 2000;13:549–60.CrossRef
Park, SY, Saijo, K, Takahashi, T, et al. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 1995;3:771–82.CrossRef
Rodig, SJ, Meraz, MA, White, JM, et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 1998;93:373–83.CrossRef
Stahl, N, Boulton, TG, Farruggella, T, et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 1994;263:92–5.CrossRef
Ursini-Siegel, J, Schade, B, Cardiff, RD, Muller, WJ. Insights from transgenic mouse models of ERBB2-induced breast cancer. Nature Reviews Cancer, 2007;7:389–97.CrossRef
Dankort, D, Maslikowski, B, Warner, N, et al. Grb2 and Shc adapter proteins play distinct roles in Neu (ERBB-2)-induced mammary tumorigenesis: implications for human breast cancer. Molecular and Cell Biology, 2001;21:1540–51.CrossRef
Irby, RB, Mao, W, Coppola, D, et al. Activating SRC mutation in a subset of advanced human colon cancers. Nature Genetics, 1999;21:187–90.CrossRef
Hantschel, O, Superti-Furga, G. Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nature Reviews Molecular and Cell Biology, 2004;5:33–44.CrossRef
Heisterkamp, N, Stam, K, Groffen, J, de Klein, A, Grosveld, G. Structural organization of the bcr gene and its role in the Ph’ translocation. Nature 1985;315:758–61.CrossRef
Li, S. Src-family kinases in the development and therapy of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia. Leukemia and Lymphoma 2008;49:19–26.CrossRef
Ray, A, Cowan-Jacob, SW, Manley, PW, Mestan, J, Griffin, JD. Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis study. Blood 2007;109:5011–15.CrossRef
Azam, M, Latek, RR, Daley, GQ. Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL. Cell 2003;112:831–43.CrossRef
Liang, F, Luo, Y, Dong, Y, et al. Translational control of Csk expression by PRL3 phosphatase. Journal of Biological Chemistry 2008;283:10 339–46.CrossRefGoogle ScholarPubMed
Hamaguchi, M, Matsuyoshi, N, Ohnishi, Y, et al. p60v-src causes tyrosine phosphorylation and inactivation of the N- cadherin-catenin cell adhesion system. EMBO Journal 1993;12:307–14.
Genda, T, Sakamoto, M, Ichida, T, Asakura, H, Hirohashi, S. Loss of cell-cell contact is induced by integrin-mediated cell-substratum adhesion in highly-motile and highly-metastatic hepatocellular carcinoma cells. Laboratory Investigation, 2000;80:387–94.CrossRef

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×